Bone Metastases Clinical Trials

23 recruiting

Bone Metastases Trials at a Glance

29 actively recruiting trials for bone metastases are listed on ClinicalTrialsFinder across 6 cities in 13 countries. The largest study group is Not Applicable with 9 trials, with the heaviest enrollment activity in Bologna, Jinan, and Guangzhou. Lead sponsors running bone metastases studies include Costantino Errani, Fudan University, and Istituto Ortopedico Rizzoli.

Browse bone metastases trials by phase

Treatments under study

About Bone Metastases Clinical Trials

Looking for clinical trials for Bone Metastases? There are currently 23 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Bone Metastases trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Bone Metastases clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 29 trials

Recruiting

Registry for Bone Metastases

Bone Metastases
Memorial Sloan Kettering Cancer Center500 enrolled7 locationsNCT07391410
Recruiting
Phase 3

Post-Op Pain Control for Prophylactic Intramedullary Nailing.

PainBone MetastasesOpioid Use+2 more
St. Louis University60 enrolled1 locationNCT03823534
Recruiting

Prospective Evaluation of Interventional Studies on Bone Metastases - the PRESENT Cohort

Bone Metastases
UMC Utrecht2,500 enrolled1 locationNCT02356497
Recruiting
Not Applicable

SBRT Technique Implementation for Spinal Metastases Irradiation

Bone MetastasesSpinal MetastasesSpinal Tumors
Institute of Oncology Ljubljana100 enrolled2 locationsNCT07429422
Recruiting
Not Applicable

Early Radiotherapy Versus Observation for High-risk Asymptomatic or Minimally Symptomatic Bone Metastases

Bone MetastasesSolid NeoplasmsAsymptomatic or Minimally Symptomatic+1 more
Cancer Research Antwerp120 enrolled8 locationsNCT07146074
Recruiting
Phase 3

A Phase III Randomized Trial Comparing Stereotactic Body Radiation Therapy (SBRT) vs Conventional Palliative Radiation Therapy for Painful Bone Metastases

Bone Metastases
M.D. Anderson Cancer Center220 enrolled1 locationNCT06065449
Recruiting
Phase 1

Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain

Bone PainMetastatic Bone TumorBone Metastases in Subjects With Advanced Cancer
Telix Pharmaceuticals (Innovations) Pty Limited33 enrolled3 locationsNCT07197645
Recruiting
Phase 2

A Trial of SHR-2017 Injection in Patients With Bone Metastases From Solid Tumors

For Prevention of Bone Events in Patients With Bone Metastases From Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.210 enrolled1 locationNCT07028268
Recruiting

BOne Metastases REgistry for Patients Undergoing cryoAbLation With curatIve purpoSe

Bone Metastases
Cardiovascular and Interventional Radiological Society of Europe50 enrolled5 locationsNCT06480955
Recruiting

Fracture Risk Evaluation of Bone Metastases Derived From Carcinoma

Bone Metastases
Costantino Errani250 enrolled1 locationNCT06524843
Recruiting
Not Applicable

Simulation-Free, Single-Fraction Palliative Radiation Therapy for Treatment of Bone Metastases

Bone Metastases
University of Utah40 enrolled1 locationNCT07202273
Recruiting
Not Applicable

Research on the Optimization of Treatment for Spinal Metastases With Radioactive Particle Implantation Using TPS and Mechanical Dual Simulation

Bone Metastases in Subjects With Advanced Cancer
Li Min150 enrolled1 locationNCT07171996
Recruiting

Radiotherapy Treatments for Neoplasms of the Limbs

Bone MetastasesBone Neoplasms
European Institute of Oncology3,000 enrolled1 locationNCT06335251
Recruiting

Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method?

SarcomaBone MetastasesProximal Femur Replacement
Duke University50 enrolled1 locationNCT03261544
Recruiting

Development of Innovative Preclinical Ex Vivo Models for the Study of Sarcomas and Metastases From Solid Tumors

Lung MetastasesBone Metastases From Solid TumorsBone and Soft Tissue Tumors
Istituto Ortopedico Rizzoli125 enrolled1 locationNCT07112989
Recruiting
Not Applicable

SFRT and SCART in Radiotherapy for Bone Metastases With Soft Tissue

Bone Metastases in Subjects With Advanced Cancer
Shandong Cancer Hospital and Institute90 enrolled1 locationNCT06987370
Recruiting

Arterial Embolization for the Treatment of Bone Metastases: Prospective Observational Study

Bone Metastases
Istituto Ortopedico Rizzoli60 enrolled1 locationNCT06189079
Recruiting

The Feasibility and Safety of Conventional external beam radiation therapy (EBRT) and Integrated Stereotactic Gross Tumour Volume (GTV) Boost in Bone Metastases

Bone Metastases
GenesisCare100 enrolled8 locationsACTRN12625000615482
Recruiting
Not Applicable

Stereotactic Multiple Fraction Radiotherapy for Non-spine Bone Metastases

PainBone MetastasesRadiation Therapy
Kantonsspital Winterthur KSW162 enrolled2 locationsNCT05406063
Recruiting

Analysis of Intramedullary Nail and Prosthetic Reconstruction After Surgical Treatment of Bone Metastases of Proximal Femur

Bone Metastases
Costantino Errani600 enrolled1 locationNCT06918860